The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Celgene; Genentech; Ipsen; Lilly; Novartis
Research Funding - Incyte; Ipsen; Lexicon; Novartis; Sanofi

Final progression-free survival (PFS) analyses for lanreotide autogel/depot 120 mg in metastatic enteropancreatic neuroendocrine tumors (NETs): The CLARINET extension study.
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen
 
Marianne Pavel
Honoraria - Ipsen; Lexicon; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Ipsen (Inst); Novartis (Inst)
 
Jaroslaw B Cwikla
Travel, Accommodations, Expenses - Ipsen; Ipsen (I)
 
Alexandria T. Phan
No Relationships to Disclose
 
Markus Raderer
Honoraria - Celgene; Eisai; Ipsen; Novartis; Roche
 
Eva Sedlackova
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Ipsen; Merck; Novartis
Research Funding - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; Merck; Novartis; Roche
 
Guillaume Cadiot
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Keocyt; Novartis
Research Funding - Ipsen
 
Jaume Capdevila
No Relationships to Disclose
 
Lucy Wall
Research Funding - AstraZeneca (I); Merck (I); Novartis (I)
Travel, Accommodations, Expenses - Bayer; Ipsen
Other Relationship - Novartis
 
Guido Rindi
Speakers' Bureau - Ipsen; Novartis
 
Catherine Lombard-Bohas
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Ipsen; Novartis
 
Nilani Liyanage
Employment - Ipsen
 
Xuan Mai Truong Thanh
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Philippe Ruszniewski
Employment - Ipsen (I)
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Ipsen; Novartis
Research Funding - Ipsen; Novartis
 
Martyn E. Caplin
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Ipsen; Novartis